Citation:
J Drug Discov Develop and Deliv. 2016; 3(1): 1020
Abstract:
Drugs for curing any cancer must completely destroy a patient’s cancer
without harming the patient. To avoid harming the patient, precision-targeted
drugs are used to inactivate RNA transcripts that are absent from the patient’s
normal cells, but present in and essential to the viability of the patient’s cancer.
Such “cancer-essential” transcripts are from embryo-active genes normally
deactivated in adults, but reactivated in cancers, or from oncogenic viruses. For
complete destruction of the patient’s cancer a “custom cocktail” of precisiontargeted
drugs will target multiple cancer-essential transcripts found to be
present in and essential to that patient’s cancer.
This paper describes: the basis for selecting targets in a patient’s cancer;
selecting drugs for precisely inactivating those targets; and, assembly of a
custom cocktail of such drugs designed to provide a safe and effective cure
for that patient’s cancer. Preparation and use of a custom cocktail for a specific
patient entails:
1. A biopsy of the patient’s cancer is sequenced to identify the canceressential
transcripts present in that cancer.
2. With that information, assemble a cocktail of precision-targeted drugs
effective against multiple cancer-essential transcripts found to be present in that
patient’s cancer, and treat the patient with that custom cocktail.
Also described is a basis for possibly obtaining prompt and affordable
regulatory approvals for such cocktails.
I believe this therapeutics strategy solves the central challenge in treating
cancers: how to completely destroy any cancer without harming the patient. It
also offers a direct and rapid route to a safe, effective, and affordable treatment
for any cancer.
Epub:
Not Epub
Link to Publication:
http://austinpublishinggroup.com/drug-development/download.php?file=fulltext/drug-v3-id1020.pdf